The rate of clinical symptoms of patients with positive serology including skin rash or pruritus, digestive dysfunction, headache, fever, weakness or limb pain, cough, and visual loss were 34.51%, 27.82%, 10.92%, 10.56%, 6.34%, 3.17%, and 3.17% respectively.